0001203311-17-000074.txt : 20170908 0001203311-17-000074.hdr.sgml : 20170908 20170908193253 ACCESSION NUMBER: 0001203311-17-000074 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170906 FILED AS OF DATE: 20170908 DATE AS OF CHANGE: 20170908 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cline Darren S CENTRAL INDEX KEY: 0001633639 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-32405 FILM NUMBER: 171077644 MAIL ADDRESS: STREET 1: 21823 30TH DRIVE SE CITY: BOTHELL STATE: WA ZIP: 98021 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SEATTLE GENETICS INC /WA CENTRAL INDEX KEY: 0001060736 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 911874389 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 21823 30TH DRIVE SE STREET 2: SUITE CITY: BOTHELL STATE: WA ZIP: 98021 BUSINESS PHONE: 4255274000 MAIL ADDRESS: STREET 1: 21823 30TH DRIVE SE STREET 2: SUITE CITY: BOTHELL STATE: WA ZIP: 98021 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2017-09-06 0 0001060736 SEATTLE GENETICS INC /WA SGEN 0001633639 Cline Darren S 21823 30TH DRIVE SE BOTHELL WA 98021 0 1 0 0 EVP, Commercial Common Stock 2017-09-06 4 M 0 5024 16.41 A 77230 D Common Stock 2017-09-06 4 M 0 5024 15.46 A 82254 D Common Stock 2017-09-06 4 S 0 5024 51.944 D 77230 D Incentive Stock Option (right to buy) 16.41 2017-09-06 4 M 0 5024 0.0 D 2020-10-29 Common Stock 5024 0 D Non-Qualified Stock Option (right to buy) 15.46 2017-09-06 4 M 0 5024 0.0 D 2021-08-24 Common Stock 5024 2268 D Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. Shares vested at a rate of 25% on October 29, 2011 and monthly thereafter until all the shares are fully vested on October 29, 2014. Shares vested at a rate of 25% on August 24, 2012 and monthly thereafter until all the shares are fully vested on August 24, 2015. /s/ Jean Liu 2017-09-08